Oscar Health (NYSE:OSCR – Get Free Report) had its target price boosted by equities research analysts at Wells Fargo & Company from $12.00 to $20.00 in a research report issued on Thursday, Benzinga reports. The firm presently has an “overweight” rating on the stock. Wells Fargo & Company‘s price target would indicate a potential upside […]